A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration
- David Chin-Yee
- , Thomas Eck
- , Susan Fowler
- , Angela Hardi
- , Rajendra S. Apte
- Department of Ophthalmology and Visual Sciences
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Center of Regenerative Medicine
- DBBS - Neurosciences
- DBBS - Developmental, Regenerative and Stem Cell Biology
- Bursky Center for Human Immunology and Immunotherapy
Research output: Contribution to journal › Review article › peer-review
109
Link opens in a new tab
Scopus
citations